Undertreatment of patients with localized extranodal compared with nodal diffuse large B-cell lymphoma

References

• Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127:2893–2917.
   PubMed Web of Science ®Google Scholar
• Krol AD, le Cessie S, Snijder S, et al. Primary extranodal non-Hodgkin's lymphoma (NHL): the impact of alternative definitions tested in the Comprehensive Cancer Centre West population-based NHL registry. Ann Oncol 2003;14:131–139.
   PubMed Web of Science ®Google Scholar
• d’Amore F, Christensen BE, Brincker H, et al. Clinicopathological features and prognostic factors in extranodal non-Hodgkin lymphomas. Danish LYFO Study Group. Eur J Cancer 1991;27: 1201–1208.
   PubMed Web of Science ®Google Scholar
• Otter R, Gerrits WB, vd Sandt MM, et al. Primary extranodal and nodal non-Hodgkin's lymphoma. A survey of a population-based registry. Eur J Cancer Clin Oncol 1989;25:1203–1210.
   PubMed Web of Science ®Google Scholar
• Moller MB, Pedersen NT, Christensen BE. Diffuse large B-cell lymphoma: clinical implications of extranodal versus nodal presentation–a population-based study of 1575 cases. Br J Haematol 2004;124:151–159.
   PubMed Web of Science ®Google Scholar
• Krol AD, Hermans J, Dawson L, et al. Treatment, patterns of failure, and survival of patients with stage I nodal and extranodal non-Hodgkin's lymphomas, according to data in the population-based registry of the Comprehensive Cancer Centre West. Cancer 1998; 83:1612–1619.
   PubMed Web of Science ®Google Scholar
• Glass AG, Karnell LH, Menck HR. The National Cancer Data Base report on non-Hodgkin's lymphoma. Cancer 1997;80:2311–2320.
   PubMed Web of Science ®Google Scholar
• Lopez-Guillermo A, Colomo L, Jimenez M, et al. Diffuse large B-cell lymphoma: clinical and biological characterization and outcome according to the nodal or extranodal primary origin. J Clin Oncol 2005;23:2797–2804.
   PubMed Web of Science ®Google Scholar
• Gutierrez-Garcia G, Colomo L, Villamor N, et al. Clinico-biological characterization and outcome of primary nodal and extranodal diffuse large B-cell lymphoma in the rituximab era. Leuk Lymphoma 2010;51:1225–1232.
   PubMed Web of Science ®Google Scholar
• Luminari S, Cesaretti M, Rashid I, et al. Incidence, clinical characteristics and survival of malignant lymphomas: a population-based study from a cancer registry in northern Italy. Hematol Oncol 2007;25:189–197.
   PubMed Web of Science ®Google Scholar
• Raghoebier S, Kramer MH, van Krieken JH, et al. Essential differences in oncogene involvement between primary nodal and extranodal large cell lymphoma. Blood 1991;78:2680–2685.
   PubMed Web of Science ®Google Scholar
• Clark HM, Jones DB, Wright DH. Cytogenetic and molecular studies of t(14;18) and t(14;19) in nodal and extranodal B-cell lymphoma. J Pathol 1992;166:129–137.
   PubMed Web of Science ®Google Scholar
• Kramer MH, Hermans J, Parker J, et al. Clinical significance of bcl2 and p53 protein expression in diffuse large B-cell lymphoma: a population-based study. J Clin Oncol 1996;14:2131–2138.
   PubMed Web of Science ®Google Scholar
• Offit K, Lo CF, Louie DC, et al. Rearrangement of the bcl-6 gene as a prognostic marker in diffuse large-cell lymphoma. N Engl J Med 1994;331:74–80.
   PubMed Web of Science ®Google Scholar
• Kramer MH, Hermans J, Wijburg E, et al. Clinical relevance of BCL2, BCL6, and MYC rearrangements in diffuse large B-cell lymphoma. Blood 1998;92:3152–3162.
   PubMed Web of Science ®Google Scholar
• Houldsworth J, Mathew S, Rao PH, et al. REL proto-oncogene is frequently amplified in extranodal diffuse large cell lymphoma. Blood 1996;87:25–29.
   PubMed Web of Science ®Google Scholar
• Rao PH, Houldsworth J, Dyomina K, et al. Chromosomal and gene amplification in diffuse large B-cell lymphoma. Blood 1998;92: 234–240.
   PubMed Web of Science ®Google Scholar
• Gronbaek K, Straten PT, Ralfkiaer E, et al. Somatic Fas mutations in non-Hodgkin's lymphoma:association with extranodal disease and autoimmunity. Blood 1998;92:3018–3024.
   PubMed Web of Science ®Google Scholar
• Du MQ, Isaccson PG. Gastric MALT lymphoma:from aetiology to treatment. Lancet Oncol 2002;3:97–104.
   PubMed Web of Science ®Google Scholar
• Hyjek E, Isaacson PG. Primary B cell lymphoma of the thyroid and its relationship to Hashimoto's thyroiditis. Hum Pathol 1988;19: 1315–1326.
   PubMed Web of Science ®Google Scholar
• Batchelor T, Loeffler JS. Primary CNS lymphoma. J Clin Oncol 2006;24:1281–1288.
   PubMed Web of Science ®Google Scholar
• Krol AD, Hermans J, Kramer MH, et al. Gastric lymphomas compared with lymph node lymphomas in a population-based registry differ in stage distribution and dissemination patterns but not in patient survival. Cancer 1997;79:390–397.
   PubMed Web of Science ®Google Scholar
• Gundrum JD, Mathiason MA, Moore DB, et al. Primary testicular diffuse large B-cell lymphoma: a population-based study on the incidence, natural history, and survival comparison with primary nodal counterpart before and after the introduction of rituximab. J Clin Oncol 2009;27:5227–5232.
   PubMed Web of Science ®Google Scholar
• Available from: www.iknl.nl
   Google Scholar
• Available from: www.palga.nl
   Google Scholar
• Percy CL, Holten VV, Muir CS. International classification of diseases for oncology. Geneva: World Health Organization; 1990.
   Google Scholar
• Fritz AG. International classification of diseases for oncology ICD-O3. Geneva: World Health Organization; 2000.
   Google Scholar
• van de Schans SA, Issa DE, Visser O, et al. Diverging trends in incidence and mortality, and improved survival of non-Hodgkin's lymphoma, in the Netherlands, 1989–2007. Ann Oncol 2011;23: 171–182.
   PubMed Web of Science ®Google Scholar
• Kuper-Hommel MJJ, Vrints LW, Coebergh JWW, Vreugdenhil G. High grade MALT-lymphoma of the breast. Neth J Med 1999;54: 235–238.
   PubMed Web of Science ®Google Scholar
• Available from: www.nccn.org/professionals/physician_gls/pdf/nhl.pdf
   Google Scholar
• Janssen-Heijnen ML, van Spronsen DJ, Lemmens VE, et al. A population-based study of severity of comorbidity among patients with non-Hodgkin's lymphoma: prognostic impact independent of International Prognostic Index. Br J Haematol 2005;129:597–606.
   PubMed Web of Science ®Google Scholar
• van Spronsen DJ, Janssen-Heijnen ML, Lemmens VE, et al. Independent prognostic effect of co-morbidity in lymphoma patients: results of the population-based Eindhoven Cancer Registry. Eur J Cancer 2005;41:1051–1057.
   PubMed Web of Science ®Google Scholar
• Bradford PT, Devesa SS, Anderson WF, et al. Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases. Blood 2009;113:5064–5073.
   PubMed Web of Science ®Google Scholar
• Abrey LE, DeAngelis LM, Yahalom J. Long-term survival in primary CNS lymphoma. J Clin Oncol 1998;16:859–863.
   PubMed Web of Science ®Google Scholar
• Gurney KA, Cartwright RA, Gilman EA. Descriptive epidemiology of gastrointestinal non-Hodgkin's lymphoma in a population-based registry. Br J Cancer 1999;79:1929–1934.
   PubMed Web of Science ®Google Scholar
• Severson RK, Davis S. Increasing incidence of primary gastric lymphoma. Cancer 1990;66:1283–1287.
   PubMed Web of Science ®Google Scholar
• Devesa SS, Fears T. Non-Hodgkin's lymphoma time trends: United States and international data. Cancer Res 1992;52:5432s–5440s.
   PubMed Web of Science ®Google Scholar
• d’Amore F, Brincker H, Gronbaek K, et al. Non-Hodgkin's lymphoma of the gastrointestinal tract: a population-based analysis of incidence, geographic distribution, clinicopathologic presentation features, and prognosis. Danish Lymphoma Study Group. J Clin Oncol 1994;12:1673–1684.
   PubMed Web of Science ®Google Scholar
• Morton JE, Leyland MJ, Vaughan HG, et al. Primary gastrointestinal non-Hodgkin's lymphoma: a review of 175 British National Lymphoma Investigation cases. Br J Cancer 1993;67:776–782.
   PubMed Web of Science ®Google Scholar
• Koch P, Probst A, Berdel WE, et al. Treatment results in localized primary gastric lymphoma: data of patients registered within the German multicenter study (GIT NHL 02/96). J Clin Oncol 2005;23: 7050–7059.
   PubMed Web of Science ®Google Scholar
• Luminari S, Cesaretti M, Marcheselli L, et al. Decreasing incidence of gastric MALT lymphomas in the era of anti-Helicobacter pylori interventions: results from a population-based study on extranodal marginal zone lymphomas. Ann Oncol 2010;21:855–859.
   PubMed Web of Science ®Google Scholar
• Parsonnet J, Friedman GD, Vandersteen DP, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991;325:1127–1131.
   PubMed Web of Science ®Google Scholar
• Huang JQ, Sridhar S, Chen Y, et al. Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology 1998;114:1169–1179.
   PubMed Web of Science ®Google Scholar
• Ekstrom AM, Hansson LE, Signorello LB, et al. Decreasing incidence of both major histologic subtypes of gastric adenocarcinoma–a population-based study in Sweden. Br J Cancer 2000;83:391–396.
   PubMed Web of Science ®Google Scholar
• Loffeld RJ, van der Putten AB. Changes in prevalence of Helicobacter pylori infection in two groups of patients undergoing endoscopy and living in the same region in the Netherlands. Scand J Gastroenterol 2003;38:938–941.
   PubMed Web of Science ®Google Scholar
• Roosendaal R, Kuipers EJ, Buitenwerf J, et al. Helicobacter pylori and the birth cohort effect: evidence of a continuous decrease of infection rates in childhood. Am J Gastroenterol 1997;92: 1480–1482.
   PubMed Web of Science ®Google Scholar
• Kuo SH, Yeh KH, Wu MS, et al. H. pylori eradication therapy is effective in the treatment of early-stage H. pylori-positive gastric diffuse large B-cell lymphomas. Blood 2012;119:4838–4844.
   PubMed Web of Science ®Google Scholar
• Zinzani PL, Martelli M, Bertini M, et al. Induction chemotherapy strategies for primary mediastinal large B-cell lymphoma with sclerosis: a retrospective multinational study on 426 previously untreated patients. Haematologica 2002;87:1258–1264.
   PubMed Web of Science ®Google Scholar
• Savage KJ, Al-Rajhi N, Voss N, et al. Favorable outcome of primary mediastinal large B-cell lymphoma in a single institution: the British Columbia experience. Ann Oncol 2006;17:123–130.
   PubMed Web of Science ®Google Scholar